Next Century Growth Investors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-89,346
Closed -$4.47M 126
2021
Q3
$4.47M Sell
89,346
-18,323
-17% -$999K 0.39% 84
2021
Q2
$5.98M Sell
107,669
-55,451
-34% -$2.95M 0.47% 66
2021
Q1
$7.63M Sell
163,120
-3,123
-2% -$151K 0.58% 58
2020
Q4
$7.24M Buy
166,243
+48,391
+41% +$1.79M 0.61% 54
2020
Q3
$4.31M Sell
117,852
-9,349
-7% -$318K 0.45% 70
2020
Q2
$3.71M Buy
+127,201
New +$3.52M 0.42% 77
2019
Q4
Sell
-42,649
Closed -$1.35M 131
2019
Q3
$1.35M Buy
+42,649
New +$1.68M 0.22% 101

Other funds holding HCAT

Next Century Growth Investors's HCAT Position: Q4 2021 in Review

Next Century Growth Investors sold out of Health Catalyst (HCAT) in Q4 2021, closing a stake of 89,346 shares — an estimated $4.47M sold.

Next Century Growth Investors first reported a position in HCAT in Q3 2019 and held it in 7 quarters. The position peaked at $7.63M in Q1 2021. 186 funds tracked by Wall St. Rank hold HCAT as of Q4 2021.

  • Next Century Growth Investors reported no remaining Health Catalyst position as of Q4 2021 after selling out during the quarter.
  • Next Century Growth Investors sold 89,346 Health Catalyst shares in Q4 2021, an estimated $4.47M.
  • Next Century Growth Investors first reported a position in Health Catalyst in Q3 2019 and held it in 7 quarters.
  • Next Century Growth Investors's Health Catalyst position peaked at $7.63M in Q1 2021.
  • 186 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2021.

Based on Next Century Growth Investors's 13F filing for Q4 2021, filed 14 Feb 2022.